Women's Health & Gynecology Clinical Trials Update: Week 33, 2026

Published August 14, 2026 — 5 trials covered

By Victor Lafforgue, Founder of TrialsAlert. Blog posts are AI-drafted from ClinicalTrials.gov source data and reviewed by the editorial team. See our editorial policy for details.

Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali

This large Phase 4 trial is testing whether giving oral azithromycin to pregnant women and their infants can reduce the number of stillbirths and infant deaths in Mali. Nearly 100,000 participants are enrolled at one site in a region where infant mortality rates are high. If the treatment proves effective, it could provide a simple and widely accessible way to save many lives in similar settings.

GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries

This Phase 2 study compares two types of radiation therapy—photon and proton—in patients with newly diagnosed gynecologic cancers, including cervical cancer. Researchers want to see if proton therapy leads to fewer side effects than the more common photon therapy. The trial is currently recruiting adults undergoing pelvic nodal irradiation at multiple sites in the United States. The findings could help improve the quality of life for patients during and after cancer treatment.

Uterus Transplantation to Treat Infertility

This Phase 2 trial explores uterus transplantation as a way to help women with uterine factor infertility become pregnant and give birth. The study involves living donors and recipients who use frozen embryos. If successful, this approach could offer new hope for women who cannot carry a pregnancy due to the absence of a functioning uterus, allowing them to experience pregnancy and childbirth.

Low Dose Aspirin vs Placebo in Prevention of Recurrent Spontaneous Preterm Labour

This upcoming trial aims to test whether low-dose aspirin can prevent recurrent spontaneous preterm labor in pregnant women who have had premature births before. Preventing early labor could lead to healthier pregnancies and babies. Although the study is not yet recruiting, it plans to follow participants through pregnancy until delivery or 36 weeks, offering potential new tools for managing pregnancy risks.

Advancing Female University Students' Health Through Mobile Technology in Ethiopia

This trial is testing a mobile technology program designed to improve sexual and reproductive health, nutrition, and psychosocial well-being among female university students in Ethiopia. By reaching young women through their phones, the study hopes to provide support in environments where traditional health services may be limited. The trial is recruiting 880 first-year female students at one university and could inform future health interventions using digital tools.

TrialsAlert subscribers received the full impact-classified briefing and doctor-ready report this week. Get weekly briefings at trialsalert.com.